Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/8/2025

Management of Minimal Subarachnoid Hemorrhage

Initial Management

  • The American Heart Association recommends transfer to a high-volume center (>35 SAH admissions per year) with multidisciplinary capabilities including neurosurgeons, neuroendovascular specialists, and neurointensivists for optimal outcomes 1, 3
  • Care should be provided in a neurocritical care unit by a specialized team using evidence-based protocols 4
  • Urgent cerebrospinal fluid (CSF) diversion should be performed if acute symptomatic hydrocephalus develops 4
  • Blood pressure should be controlled to avoid severe hypotension, hypertension, and BP variability 5
  • Emergency reversal of anticoagulants should be performed if the patient is on them 4

Aneurysm Management

  • Evaluation of the ruptured aneurysm by both endovascular and neurosurgical specialists is necessary to determine the optimal treatment approach 4
  • Primary coiling is recommended for aneurysms amenable to both coiling and clipping in the anterior circulation to improve 1-year functional outcomes 5
  • Coiling is preferred over clipping for posterior circulation aneurysms 4
  • Partial treatment to secure the rupture site followed by delayed definitive treatment is reasonable if complete obliteration is not feasible acutely 5

Prevention of Delayed Cerebral Ischemia

  • Oral nimodipine 60 mg every 4 hours for 21 consecutive days should be administered, starting within 96 hours of hemorrhage onset 1
  • Euvolemia should be maintained rather than inducing hypervolemia, as hypervolemia has not been shown to improve outcomes and may be harmful 3, 6
  • Prophylactic hemodynamic augmentation should be avoided in patients at risk for delayed cerebral ischemia (DCI) 1
  • Elevating blood pressure while maintaining euvolemia can be beneficial for patients who develop symptomatic DCI 1

Monitoring and Management of Complications

  • Frequent neurological assessments, vital sign monitoring, and validated dysphagia screening protocols should be implemented 4
  • Transcranial Doppler (TCD) should be used to monitor for vasospasm, though its sensitivity and specificity are variable 6
  • Lindegaard ratios in the range of 5-6 indicate severe spasm and should be treated based on clinical situation 6
  • Standardized ICU care bundles should be used when mechanical ventilation is required 4
  • Venous thromboembolism prophylaxis should be initiated once the aneurysm is secured 4
  • Routine use of statins, intravenous magnesium, and endothelin antagonists should be avoided as they have not been shown to improve outcomes 1, 3
  • Phenytoin should be avoided for seizure prevention as it is associated with excess morbidity and mortality 4

Long-term Management

  • A multidisciplinary team approach should be implemented to identify discharge needs and design rehabilitation treatment 1, 2
  • Validated screening tools should be used to identify physical, cognitive, and behavioral deficits 2
  • Interventions for mood disorders should be provided to improve long-term outcomes 2
  • Cerebrovascular imaging should be performed after treatment and subsequent monitoring to identify remnants, recurrence, or growth of treated aneurysms 2